Publications

Okore LA, Aggarwal R, Awuor DR, Owuor PM. Knowledge, attitudes, behaviors, and consequences of geogenic fluoride exposure on oral and dental health in Nakuru, Kenya. Frontiers in oral health. 2026. PMID: 41939973

Varga C, Robinson M, Davis JA, Hashmi H, Martin TG, Kumar A, Sborov DW, Wagner CB, Hansen DK, Castaneda Puglianini O, Shune L, Bhurtel E, Afrough A, Anderson LD, Dhakal B, Herr MM, Richard S, Lieberman-Cribbin A, Sherbenou D, Forsberg PA, Purvey S, Khouri J, Lin Y, Sidana S, Patel KK, Kocoglu M, Midha S, Ferreri CJ. Efficacy of stem cell boost (SCB) for chimeric antigen receptor-T cell therapy (CAR-T)-related hematologic toxicity in patients with relapsed/refractory multiple myeloma (RRMM)-real world experience from the US multiple myeloma immunotherapy consortium. Blood cancer journal. 2026. PMID: 41862439

Rugo HS, Tolaney SM, Cortés J, Marmé F, de Azambuja E, Xu B, Sohn J, Naito Y, Valdez T, Gary D, Zhu J, Lai C, Bardia A. Sacituzumab govitecan in patients with metastatic breast cancer: pooled safety analysis of data from patients in North America, Europe, and Asia. ESMO open. 2026. PMID: 41861751

Xiao S, Wang M, Martin TG, Scott B, Fang X, Liu X, Yang Y, Fu S, Truong SD, Gugel JF, Maas GL, Mullen MP, Hill JH, Li VL, Markhard AL, Zhao M, Qi W, Reghupaty SC, Zhao M, Spaas J, Wei W, Moholdt T, Hawley JA, Voldstedlund CT, Richter EA, Chen X, Svensson KJ, Bernstein D, Leinwand LA, Xu Y, Long JZ. Python metabolomics uncovers a conserved postprandial metabolite and gut-brain feeding pathway. Nature metabolism. 2026. PMID: 41857429

O'Neill AF, Zeme EL, Abou-Alfa GK, Baretti M, Bondoc AJ, Church A, Ferrone CR, Fitzgerald M, Geller JI, Gill AE, Harris WP, Kim HB, Lee SS, Liu KX, Ortiz MV, Rangaswami A, Riehle KJ, Rosenberg AR, Torbenson MS, Yarchoan M, Gordan JD. Clinical guideline for the diagnosis and treatment of fibrolamellar carcinoma. Hepatology (Baltimore, Md.). 2026. PMID: 41849750

Murthy RK, O'Brien BJ, Berry DA, Singareeka-Raghavendra A, Monroe MG, Johnson J, White J, Schwartz-Gomez J, Topletz-Erickson A, Lobbous M, Riley K, Melisko M, Morikawa A, Ferguson SD, de Groot JF, Krop IE, Valero V, Rimawi MF, Wolff AC, Tripathy D, Lin NU, Stringer-Reasor EM. Tucatinib-trastuzumab-capecitabine for treatment of leptomeningeal metastasis in women with HER2+ breast cancer: TBCRC049 phase 2 study results. Nature cancer. 2026. PMID: 41851506

Nyberg WA, Bernard PL, Ngo W, Wang CH, Ark J, Rothrock A, Borgo GM, Kimmerly GR, Jung JH, Allain V, Hamilton JR, Baldwin A, Stickels R, Wyman S, Khan SH, Lang S, Marsh D, Almudhfar N, Novick C, Mortazavi Y, Zhang S, AbdElwakil MM, Sandoval LR, Hwang S, Chu SN, Jung H, Liu C, Sharma D, McCreary T, Li Z, Satpathy AT, Carnevale J, Rutishauser RL, Cromer MK, Roybal KT, Dodgson SE, Doudna JA, Asokan A, Eyquem J. In vivo site-specific engineering to reprogram T cells. Nature. 2026. PMID: 41851456

Montoya T, Lee JV, Qiu L, Krall A, Matulionis N, Seo Y, Finck BN, Kelley RK, Christofk H, Goga A. Alanine catabolism as a targetable vulnerability for MYC-driven liver cancer. Cell reports. 2026. PMID: 41849351

Nkya A, Xu MJ, Philipo GS, Haddadi S, Ng D, Mushi BP, Malango AE, Magorosa EP, Paciorek A, Zhang L, Muya S, Ha P, Liyombo E, Richard E, Massawe W, Palefsky JM, Yom SS, Mmbaga EJ, Van Loon K. Prevalence of High-Risk Human Papillomavirus and Associated Risk Factors Among Individuals With Head and Neck Cancer in a National Referral Center in Tanzania. JCO global oncology. 2026. PMID: 41843836

Huppert LA, Fisch S, Her L, Hodgdon C, Brain S, Simmons C, Lai AR, Malevanchik L, Balassanian R, Vasudevan HN, Morshed R, Braunstein S, Boreta L, Majure M, Chien AJ, Rugo HS, Magbanua MJM, Melisko ME. Detection of actionable mutations in the cerebrospinal fluid and concordance/discordance with extracranial mutations in patients with metastatic breast cancer and leptomeningeal disease. Therapeutic advances in medical oncology. 2026. PMID: 41883874

Unno R, Akutagawa J, Song H, Hui K, Chen YA, Pham JH, Lee J, Yang H, Huang FW, Chi T. A single cell transcriptional profile of benign prostatic hyperplasia. Scientific Reports. 2026. PMID: 41832222

Expert Panel on Gastrointestinal Imaging, Yacoub JH, Yano M, Chang KJ, Bergsland E, Bhosale PR, Cash BD, Chernyak V, Gupta A, Hallet J, Halpern J, Magnetta M, Noronha CF, Refaat T, Korngold EK. ACR Appropriateness Criteria® Staging and Follow-Up of Pancreatic Neuroendocrine Tumors. Journal of the American College of Radiology : JACR. 2026. PMID: 41823937

Kwon DY, Diamond-Pott H, Stark KG, Klem RA, Restrepo Mejia M, Hazkour N, Henderson PW, Taub PJ. Bridging the Gap: Assessing the Reporting of Social Determinants of Health Across a Decade of Randomized Controlled Trials in Plastic and Reconstructive Surgery. Annals of plastic surgery. 2026. PMID: 41837754

Keenan BP, Fan Z, Le BK, Harris Q, Chen J, Clark M, Lea A, Zhang L, Cheung A, Lara F, Gordan JD, Bracci P, Behr SC, Fong L, Venook AP, Kim EJ, Kelley RK. Phase II trial with nivolumab and sorafenib in HCC identified enrichment of immunosuppressive monocytes in patients with Child-Pugh B liver dysfunction. JHEP reports : innovation in hepatology. 2026. PMID: 41831609

Delaveris CS, Loudermilk RP, Pandey A, Remesh SG, Peters-Clarke TM, Ganjave SD, Dougherty WJN, Delavan HM, Wang C, Ling J, Camara Serrano JA, Salangsang F, Ding CC, Greenland N, Chu CE, Porten S, Steri V, Chou J, Evans MJ, Leung KK, Wells JA. Autophagolysosomal exocytosis inverts Src kinase onto the cell surface in cancer. Science (New York, N.Y.). 2026. PMID: 41818370

Gracilla DE, Menon S, Breese MR, Lin YP, Dela Cruz FS, Feinberg TY, de Stanchina E, Galic AF, Allegakoen H, Perati SR, Everin N, Vizconde T, Wen NJ, Heslin A, Somwar R, Ladanyi M, Horlbeck M, Weissman JS, Sweet-Cordero EA, Bivona TG, Tulpule A. FET Fusion Oncoproteins Disrupt Physiologic DNA Repair and Create a Targetable Opportunity for ATR Inhibitor Therapy. Cancer research. 2026. PMID: 41811428

Neyazi N, Chakravarty D, Xia F, Hawes MR, Max W, Kushel M, Vijayaraghavan M. Attitudes toward tobacco-free and cannabis-free policies among residents in permanent supportive housing who use tobacco, cannabis, and other substances. Addictive behaviors reports. 2026. PMID: 41858814

Graham AJ, Khoo MWL, Srivastava V, Viragova S, Kim H, Parekh K, Hennick KM, Bird M, Goldhammer N, Yu JZ, Hu G, Brinkley NT, Pardo L, Amaya JS, Morley CD, Chadha N, Lebel P, Kumar S, Rosenbluth JM, Nowakowski TJ, Chaudhuri O, Klein O, Gómez-Sjöberg R, Gartner ZJ. Stress-relaxing granular bioprinting materials enable complex and uniform organoid self-organization. Nature materials. 2026. PMID: 41807773

Jacob S, Mayer EL, Kacik N, Storniolo AM, Isaacs C, Mayer I, Stearns V, Nanda R, Nangia J, Chien AJ, Moasser M, Melisko M, Wabl C, Muzikansky A, Geradts J, Dillon DA, Park BH, Krop I, Wolff AC, Kochupurakkal B, Shapiro GI, Rugo HS. TBCRC 035: randomized phase II pharmacodynamic study of standard and reduced-dose palbociclib with endocrine therapy in hormone receptor (HR)-positive previously treated metastatic breast cancer. ESMO open. 2026. PMID: 41812623

Gilligan T, Bohlke K, Alpert AB, Coyle N, Harichand-Herdt S, Lathan CS, Razis E, Rivera K, Sanft T, Seigel C, Times M, Chou CL. Patient-Clinician Communication: ASCO Guideline Update. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2026. PMID: 41805420